1. Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients. (4th May 2018) Authors: Jelínek, Tomáš; Maisnar, Vladimír; Pour, Luděk; Špička, Ivan; Minařík, Jiří; Gregora, Evžen; Kessler, Petr; Sýkora, Michal; Fraňková, Hana; Adamová, Dagmar; Wróbel, Marek; Mikula, Peter; Jarkovský, Jiří; Diels, Joris; Gatopoulou, Xenia; Veselá, Šárka; Besson, Hervé; Brožová, Lucie; Ito, Tetsuro; ... Journal: Current medical research and opinion Issue: Volume 34:Number 5(2018) Page Start: 775 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bortezomib retreatment for relapsed and refractory multiple myeloma in real‐world clinical practice. Issue 1 (7th December 2018) Authors: Hulin, Cyrille; de la Rubia, Javier; Dimopoulos, Meletios A.; Terpos, Evangelos; Katodritou, Eirini; Hungria, Vania; De Samblanx, Hadewijch; Stoppa, Anne‐Marie; Aagesen, Jesper; Sargin, Deniz; Sioni, Anastasia; Belch, Andrew; Diels, Joris; Olie, Robert A.; Robinson, Don; Potamianou, Anna; van de ... Journal: Health science reports Issue: Volume 2:Issue 1(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bortezomib‐based therapy for relapsed/refractory multiple myeloma in real‐world medical practice. (5th September 2018) Authors: Terpos, Evangelos; Katodritou, Eirini; de la Rubia, Javier; Hungria, Vania; Hulin, Cyrille; Roussou, Maria; Delforge, Michel; Bries, Greet; Stoppa, Anne‐Marie; Aagesen, Jesper; Sargin, Deniz; Belch, Andrew; Ahlberg, Lucia; Diels, Joris; Olie, Robert A.; Robinson, Don; Spencer, Mike; Potamianou, A... Journal: European journal of haematology Issue: Volume 101:Number 4(2018) Page Start: 556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice. Issue 12 (29th December 2022) Authors: Delforge, Michel; Vekemans, Marie-Christiane; Depaus, Julien; Meuleman, Nathalie; Van de Velde, Ann; Vande Broek, Isabelle; Vandervennet, Sophie; Van Hoorenbeeck, Sandra; Moorkens, Evelien; Strens, Danielle; Diels, Joris; Ghilotti, Francesca; Haefliger, Benjamin; Dalhuisen, Sander; Deraedt, Willi... Journal: HemaSphere Issue: Volume 6:Issue 12(2022) Page Start: e813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Burden of Respiratory Syncytial Virus in Hospitalized Children Aged ≤5 Years (INSPIRE Study). (13th April 2022) Authors: Hartmann, Katrin; Liese, Johannes G; Kemmling, Daniel; Prifert, Christiane; Weißbrich, Benedikt; Thilakarathne, Pushpike; Diels, Joris; Weber, Karin; Streng, Andrea Journal: Journal of infectious diseases Issue: Volume 226:Number 3(2022) Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma. Issue 1 (10th December 2021) Authors: Martin, Thomas; Krishnan, Amrita; Yong, Kwee; Weisel, Katja; Mehra, Maneesha; Nair, Sandhya; Qi, Keqin; Londhe, Anil; Diels, Joris; Crivera, Concetta; Jackson, Carolyn C.; Olyslager, Yunsi; Vogel, Martin; Schecter, Jordan M.; Banerjee, Arnob; Valluri, Satish; Usmani, Saad Z.; Berdeja, Jesus G.; J... Journal: EJHaem Issue: Volume 3:Issue 1(2022) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low‐Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect Comparison. (30th November 2017) Authors: Van Sanden, Suzy; Ito, Tetsuro; Diels, Joris; Vogel, Martin; Belch, Andrew; Oriol, Albert Journal: Oncologist Issue: Volume 23:Number 3(2018) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Converging or Crossing Curves: Untie the Gordian Knot or Cut it? Appropriate Statistics for Non-Proportional Hazards in Decitabine DACO-016 Study (AML). Issue 9 (September 2015) Authors: Tomeczkowski, Jörg; Lange, Ansgar; Güntert, Andreas; Thilakarathne, Pushpike; Diels, Joris; Xiu, Liang; Porre, Peter; Tapprich, Christoph Journal: Advances in therapy Issue: Volume 32:Issue 9(2015) Page Start: 854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Daratumumab monotherapy compared with historical control data in heavily pretreated and highly refractory patients with multiple myeloma: An adjusted treatment comparison. Issue 8 (5th June 2017) Authors: Usmani, Saad Z.; Diels, Joris; Ito, Tetsuro; Mehra, Maneesha; Khan, Imran; Lam, Annette Journal: American journal of hematology Issue: Volume 92:Issue 8(2017:Aug.) Page Start: E146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis. (2nd April 2020) Authors: Welty, Margaux; Mesana, Laura; Padhiar, Amie; Naessens, Dominik; Diels, Joris; van Sanden, Suzy; Pacou, Maud Journal: Current medical research and opinion Issue: Volume 36:Number 4(2020) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗